Role of KI-67, gene-suppressor P53 and oncoprotein her-2neu in prognosis for bladder cancer

Voprosy Onkologii

Volumn 52, Issue 6, 2006, Pages 643-648

  Maslyukova, Ye A ^a   Pozharisski, K M ^a   Karelin, M I ^a   Startsev, V Yu ^a   Ten, V P ^a  

^a Russian Center for Research in Radiological and Surgical Technologies   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CARCINOMA; CHEMISTRY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; UPREGULATION; UROTHELIUM;

ADULT; AGED; CARCINOMA; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MUTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33947720526     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Russian source
6. Russian source
7. Russian source
8. Russian source
9. Cordon-Cardo C., Dalbagni G., Saez G.T. et al. p53 mutations in human bladder cancer: Genotypic as phenotypic patterns // Int. J. Cancer.-1994.-Vol. 56.-P. 347-353.
10. De Vere White R.W., Stapp E. // Oncology (Huntingt).-1998.-Vol. 12.-P. 1717-1723; discussion 1724-1726.
11. Esrig D., Elmajian D., Groshen S. et al. Accumulation of nuclear p53 and tumor progression in bladder cancer // New Eng. J. Med.-1994.-Vol. 331.-P. 1259-1264.
12. Gospodarowicz M.K., Rider W.D., Keen C.W. et al. Bladder cancer: long-term follow-up results of patients treated with radical radiation // Clin. Oncol.-1991.-Vol. 3.-P. 155-161.
13. Grossman H.B., Lee C., Bromberg J., Liebert M. Expression of the alpha6 beta4 integrin provides prognostic information in bladder cancer // Oncol. Rep.-2000.-Vol. 7.-P. 13-16.
14. Harada S., Sato R., Nakamura R. et al. The correlation between spontaneous and radiation-induced apoptosis in T3B bladder cancer (histological grade G3), and the precedence between the two kinds of apoptosis for predicting clinical prognosis // Int. J. Rad. Oncol. Biol. Phys.-2000.-Vol. 48.-P. 1059-1067.
15. Jahnson S., Risberg B., Karlson M.G. et al. p53 and Rb immunostaining in locally advanced bladder cancer: Relation to prognostic variables and predictive value for the local response to radical radiotherapy // Europ. J. Urol.-1995.-Vol. 28.-P. 135-142.
16. Lara P.D., Rey A., Santana C. et al. The role of Ki-67 proliferation assessment in predicting local control in bladder cancer - patients treated by radical radiation therapy // Radiother. Oncol.-1998.-Vol. 49.-P. 163-167.
17. Nakagawa M., Emoto A., Nasu N. et al. Clinical significance of multidrug resistance associated protein and p-glycoprotein in patients with bladder cancer // J. Urol.-1997.-Vol. 157.-P. 1260-1264.
18. Ogura K., Habuchi T., YamadaH.etal.lmmunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: Positive immunostaining and radiosensitivity // Int. J. Urol. (Jap.).-1995.-Vol. 2.-P. 302-308.
19. Okamura K., Miyake K., Koshikawa T. et al. Growth fractions of transitional cell carcinoma of the bladder defined by the monoclonal antibody Ki-67 // J. Urol.-1990.-Vol. 144.-P. 875-878.
20. Osen I., Fossa S.D., Majak B. et al. Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: An immunohistochemical study // Brit. J. Urol.-1998.-Vol. 81.-P. 862-869.
21. Pfister C., Moore L., Allard R et al. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence // Clin. Cancer Res.-1999.-Vol. 5.-P. 4079-4084.
22. Plastiras D., Moutzouris G., Barbatis C. et al. Can p53 nuclear over-expression, bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumors? // Europ. J. Surg. Oncol.-1999.-Vol. 25.-R 61-65.
23. Rodel C., Grabenbauer G.G., Rodel F. et al. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation // Int. J. Rad. Oncol. Biol.Phys.-2000.-Vol. 46.-P. 1213-1221.
24. Sarkis A., Bajorin D.F., Reuter V.E. et al. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC // J. Clin. Oncol.-1995.-Vol. 13.-P. 1384-1390.